nivolumab
bms
['opdivo', 'melanoma', 'check,mate,76k', 'nivo', 'nivolumab', 'bristol', '$bmy']
$bmy bristol myers squibb presents data from checkmate -76k showing opdivo (nivolumab) reduced the risk of recurrence or death by 58% versus placebo in patients with completely resected stage iib or iic melanoma 
This is an automated account sharing new press releases in real time from https://t.co/7iCFuj68H6